Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-06

Clinical Trial Update: An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis

View source ↗

Summary

This document reports the results of an observational study of Mircera (methoxy polyethylene glycol-epoetin beta) in adults with chronic kidney disease undergoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Kidney Diseases | Status: COMPLETED | Results posted: 2017-04-06